Bone marrow fibrosis at diagnosis is associated with TP53 overexpression and adverse prognosis in low-risk myelodysplastic syndrome

MeSH terms

• Aged
• Disease-Free Survival
• Female
• Gene Expression Regulation*
• Humans
• Male
• Middle Aged
• Myelodysplastic Syndromes* / diagnosis
• Myelodysplastic Syndromes* / metabolism
• Myelodysplastic Syndromes* / mortality
• Primary Myelofibrosis* / diagnosis
• Primary Myelofibrosis* / metabolism
• Primary Myelofibrosis* / mortality
• Survival Rate
• Tumor Suppressor Protein p53 / biosynthesis*